We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




DP103 Cited as Breast Cancer Biomarker and Potential Treatment Target

By LabMedica International staff writers
Posted on 02 Sep 2014
Print article
Image: Difference in DP103 (red) levels in a healthy person (left image) and a breast cancer patient (right image) (Photo courtesy of the National University of Singapore).
Image: Difference in DP103 (red) levels in a healthy person (left image) and a breast cancer patient (right image) (Photo courtesy of the National University of Singapore).
Cancer researchers in Singapore have identified the DP103 oncogene in human breast cancers as a biomarker for the molecular processes that drive reappearance and metastasis of tumors following chemotherapy.

The 824-amino acid DEAD-box protein DP103 belongs to the family of DExD/H-box proteins, named after the signature Asp-Glu-Ala-Asp/His motif within the helicase domain (Gemin3, DDX20). DP103 was originally cloned and characterized as a component of the splicing machinery in concert with SMN, Sm, and other Gemin proteins.

Investigators at A*STAR’s Institute of Molecular and Cell Biology (Singapore) and at the National University of Singapore's Cancer Science Institute have identified DP103 as a biomarker and metastasis-driving oncogene in human breast cancers. Furthermore, they determined that DP103 elevated matrix metallopeptidase 9 (MMP9) levels, which are associated with metastasis and invasion through activation of NF-kappaB.

The NF-kappaB family of transcription factors comprises five structurally related proteins that form homo- and heterodimers through their highly conserved DNA binding/dimerization Rel homology domain. Binding of NF-kappaB to IkappaB proteins maintains NF-kappaB in an inactive state. Activation of NF-kappaB in normal cells is inducible and is a tightly controlled event. Upon stimulation, IkappaBs are phosphorylated by the IkappaB kinase (IKK) complex (consisting of IKK1, IKK2, and NEMO proteins). IkappaB phosphorylation leads to its rapid proteolysis, thereby allowing NF-kappaB to function as a transcription factor.

Reduction of DP103 expression in invasive breast cancer cells reduced phosphorylation of IKK2, abolished NF-kappaB–mediated MMP9 expression, and impeded metastasis in a mouse xenograft model. In breast cancer patient tissues, elevated levels of DP103 correlated with enhanced MMP9, reduced overall survival, and reduced survival after relapse.

Together, these findings, which were published in the August 1, 2014, online edition of the Journal of Clinical Investigation, indicated that a positive DP103/NF-kappaB feedback loop promoted continual NF-kappaB activation in invasive breast cancers and activation of this pathway was linked to cancer progression and the acquisition of chemotherapy resistance. Thus, DP103 also has potential as a therapeutic target for breast cancer treatment.

“DP103 is a novel biomarker that could help doctors select appropriate treatments for breast cancer patients at an early stage. It is also a therapeutic target which could be explored further to develop drugs that suppress breast cancer growth, as well as metastasis,” said contributing author Dr. Alan Kumar, assistant professor of pharmacology at the National University of Singapore.

“Doctors are unable to tell if a breast cancer patient will respond to chemotherapy until six months after the treatment has been prescribed. It is very worrisome as the ones who are not responsive to chemotherapy usually also suffer relapses due to metastasis. This DP103 gene that we found explains the link and will facilitate doctors in selecting suitable treatments for different cases of breast cancer,” said senior author Dr. Vinay Tergaonkar, an associate professor at the Institute of Molecular and Cell Biology.

Related Links:

A*STAR’s Institute of Molecular and Cell Biology
National University of Singapore's Cancer Science Institute


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Food Allergens Assay Kit
Allerquant 14G A
New
Thyroid ELISA Kit
AESKULISA a-TPO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.